Background: Eosinophilia is common in premature infants, though its clinical significance remains unknown. This study investigated the pattern of eosinophilia and related factors in very low birth-weight (VLBW) infants. Methods: The medical records of VLBW infants (birth body weight < 1500 g) admitted to the neonatal intensive care unit of a tertiary care center of Cheng Kung University Hospital between January 2005 and June 2007 were analyzed. Complete blood counts (CBC) with differential leukocyte counts were performed weekly. Eosinophilia was defined as an eosinophil count of more than 0.700 × 10 9 /L. The possible related factors were analyzed. Results: A total of 142 infants were recruited into the study. Those who did not survive after the first 28 days and those with less than four available CBCs were excluded, leaving 107 infants and 828 CBC measurements. Overall, 19.0% of CBCs (157/828) indicated eosinophilia and 69.0% of all infants had at least one instance of eosinophilia during their hospital stay. Eosinophilia mainly occurred in the third week of life (27.1%), with an average peak eosinophil count of 0.520 × 10 9 /L. There were 37.3% of patients with mild eosinophilia (0.700−0.999 × 10 9 /L), 50.7% with moderate eosinophilia (1.000−2.999 × 10 9 /L), and 12% with severe eosinophilia (≥ 3.000 × 10 9 /L). The demographic data and perinatal characteristics of infants with and without eosinophilia were comparable. Medical treatments including mechanical ventilation, antibiotic administration, total parenteral nutrition, intravenous catheterization, transfusion, and body weight gains were similar between the two groups. The eosinophil counts in the first week of life were significantly higher in infants with bronchopulmonary dysplasia (p < 0.05). They were also greater in VLBW infants with sepsis at the first, the third, the fourth, the fifth and the seventh weeks (p < 0.05). Conclusion: Eosinophilia is common in VLBW infants and occurs mainly in the third week of life. Higher eosinophil counts were associated with sepsis and family history of atopic eczema. Bronchopulmonary dysplasia was associated with higher eosinophil counts in the first week of life. 
Introduction
The incidence of eosinophilia in newborn infants ranges from 14−76%. 1−5 Eosinophilia is a common finding in premature infants during the neonatal period, and its incidence increases with imma turity. 1, 5 The incidence in premature infants with gestational ages less than 27 weeks is as high as 75%. 1 The reasons for the high incidence of eosinophilia are unknown.
Eosinophils normally account for only 1−3% of peripheral blood leukocytes. In neonates, eosin ophilia is defined as an eosinophil count of more than or equal to 0.700 × 10 9 /L, and has been further subclassified as mild (0.700−0.999 × 10 9 /L), moderate (1.000−2.999 × 10 9 /L), or severe (> 3.000 × 10 9 /L). 1, 3, 6 Previous studies have reported eosinophilia in association with numerous conditions, such as the establishment of an anabolic state, drug reactions, response to foreign antigens, chronic lung disease, erythropoietin treatment, total parenteral nutrition (TPN), and infections. 1, 3, 4, 7 However, its clinical significance in premature infants has yet to be determined. Previous studies have not emphasized very low birth-weight (VLBW) infants. Medical care of such premature infants varies greatly and can lead to bias in these studies. Our understanding of the significance of eosinophilia in these infants will be improved by studies that distinguish VLBW infants from other premature infants.
Eosinophilia has been proven to be related to the development of allergies; a family history of allergic disease is the major determining factor. 8−11 Therefore, the relationship between eosinophilia in early life and family history of allergy deserves further investigation. 11−13 A number of hypotheses have been proposed to explain the causes of eosinophilia in prematurity. 1, 2, 5, 6 Eosinophilia frequently occurs in severely sick premature infants, especially in those developing bronchopulmonary dysplasia (BPD). 2−4 However the clinical significance of eosinophilia in premature infants remains unknown. We hypothesized that more premature infants would be at greater risk for eosinophilia. We therefore aimed to investigate the incidence and pattern of eosinophilia and the factors associated with it in VLBW infants. Differences in the time courses, incidences, and severity of eosinophilia in VLBW infants were evaluated with respect to their different clinical conditions.
Materials and Methods
The medical records of VLBW infants (birth body weight < 1500 g) admitted to the neonatal intensive care unit (NICU) of a tertiary care center between January 2005 and June 2007 were analyzed. The following exclusion criteria were used: (1) infants who failed to survive the first 28 days; (2) infants with less than four complete blood counts (CBC); and (3) infants admitted to the NICU after 2 weeks of age.
We collected CBC data with differential leukocyte counts weekly for 8 weeks. In the case of an infection, CBC data and blood cultures were collected simultaneously. A possible association between eosinophilia and packed red blood cell (PRBC) transfusion was evaluated during the 7-day period following a PRBC transfusion.
Eosinophilia was defined as an eosinophil count of 0.700 × 10 9 /L or more, and was further subclassified into mild (0.700−0.999 × 10 9 /L), moderate (1.000−2.999 × 10 9 /L), and severe (> 3.000 × 10 9 /L) eosinophilia.
1,2 High eosinophil percentage was defined as eosinophils above 6% of total white blood cell (WBC) differential count. We defined neutropenia as absolute neutrophil count (ANC) of less than 1.100 × 10 9 /L, and neutrophilia as ANC > 15.000 × 10 9 /L in the first 60 hours of life or ANC above 6.000 × 10 9 /L thereafter, in accordance with the stringent definition of the VLBW population characterized by Mouzinho's study.
14 A WBC count of more than 35,000 was used to define leukocytosis, according the cutoff value of Hill and Duncan. 15 Data on maternal history, delivery process and postnatal course were retrieved from the medical records of the VLBW infants. Gestational age, birth weight, Apgar scores, weekly weight gain, and medical treatments such as mechanical ventilation, antibiotic administration, TPN, intravenous catheterization, transfusion, and clinical diagnoses were also documented.
The diagnosis of sepsis was based on clinical signs suggesting infection, such as recurrent apnea (three episodes within 24 hours), bradycardia, unstable body temperature, clinical deterioration, elevated C-reactive protein, and on positive blood culture results. 1, 16 BPD was diagnosed according to the clinical and radiographic features defined by National Institute of Child Health and Human Development. 17, 18 (1) Mild BPD: Treatment with oxygen > 21% for at least 28 days plus breathing of room air till 36-week postmenstrual age (PMA) or discharge, whichever comes first; (2) Moderate BPD: Treatment with oxygen > 21% for at least 28 days, plus need for < 30% oxygen till 36-week PMA or discharge, whichever comes first; (3) Severe BPD: Treatment with oxygen > 21% for at least 28 days, plus need for < 30% oxygen and/or positive pressure, (positive-pressure ventilation or nasal continuous positive airway pressure) till 36-week PMA or discharge, whichever comes first.
A family history of allergy was determined by telephone interviews performed by the case manager. Infants were considered to have a family history of allergy if there were clinical symptoms or a verified diagnosis of asthma, allergic rhinitis, allergic eczema or drug allergy in their parents, siblings or relatives. 9, 12, 13 The study was approved by the Institutional Review Board of the National Cheng Kung University Hospital. Informed consent was obtained from the parents of all infants.
Statistical analysis
The data were analyzed using SPSS version 13.0 (SPSS Inc., Chicago, IL, USA). Continuous variables were compared among groups using unpaired Student's t tests or analysis of variance, and χ 2 tests were used to compare groups with respect to categorical variables. Results are reported as mean ± SEM and p less than 0.05 was considered significant.
Results
A total of 142 VLBW infants were recruited. Thirtyfive patients were excluded and 107 infants providing 828 CBCs met the inclusion criteria. Overall, 19.0% of CBCs (157/828) showed eosinophilia, and 69.0% of infants had at least one instance of eosinophilia during their hospital stay. Eosinophilia mainly occurred in the third week of life (27.1%) with an average peak eosinophil count of 0.520 × 10 9 /L (Figures 1 and 2 ). There were 37.3% of infants with mild eosinophilia, 50.7% with moderate eosinophilia, and 12% with severe eosinophilia ( Figure 3 ). Table 1 shows the demographic data and perinatal characteristics of the infants with or without eosinophilia. There were no significant differences between the two groups with regard to any of these variables. Table 2 shows the CBC data with differential counts, absolute eosinophil counts and eosinophil percentages in infants with or without eosinophilia. Eosinophil count and eosinophil percentage were significantly correlated with WBC count only in the first week (p = 0.5), but not in later weeks. Further, the eosinophil counts in the eosinophilia group were significantly correlated with eosinophil percentage, while WBC counts were not. Table 3 shows no differences in the incidences of respiratory distress Table 4 shows no significant differences between the two groups in terms of allergic family history of asthma, allergic rhinitis or drug allergies. However, the eosinophil counts were significantly higher in infants with a family history of atopic eczema (p < 0.01). Figure 4 shows that WBC counts and neutrophil counts gradually decreased after birth and became stable at the fifth week of life. Overall, neutropenia occurred in 27 (25.2%) infants and in 5.8% of the total CBC data. Neutrophilia occurred in 82 (70.3%) infants and in 18.5% of the total CBC data in our study. Eosinophil counts changed less noticeably, in comparison to the WBC and neutrophil counts. WBC counts and neutrophil counts were significantly correlated throughout the whole observation period (p < 0.01). Eosinophil counts showed a separate trend that was significantly different from those shown by both the WBC and neutrophil counts.
Fifty-nine percent of the infants in this study had BPD. Of these, 55.7% had mild BPD, 41.1% had moderate BPD, and 3.3% had severe BPD. As shown in Figure 5 , the eosinophil count in the first week of life was higher in infants with BPD (p < 0.05). When compared to the absolute eosinophil counts (AEC) in infants without BPD, AEC in the BPD group decreased during the second week of life and remained low until after the sixth week, when the AEC in this group became higher. The use of postnatal steroids in infants with BPD was higher than in those without BPD, although the difference was not significant (p = 0.075). The effects of infection on eosinophil counts were evaluated, as shown in Figure 6 . Fifty-four infants had sepsis, of which 75.8% had eosinophilia. Among all infants with infection, only 24.2% were without eosinophilia, 24.2% had mild eosinophilia, 40.3% had moderate eosinophilia and 11.3% had severe eosinophilia. The eosinophil counts in VLBW infants with sepsis were higher than in those without during the first (positive blood culture: 11 cases), third (18 cases), fourth (13 cases), fifth (8 cases) and seventh (8 cases) weeks (p < 0.05). However, the eosinophil counts were similar in VLBW infants with and without sepsis during the second (positive blood culture: 7 cases), sixth (3 cases) and eighth (4 cases) weeks of postnatal age.
Discussion
In this retrospective study, 69% of all infants had at least one instance of eosinophilia during their hospital stay. Its peak incidence occurred in the third week of life. The degree of eosinophilia was mild in 37.3% (0.700−0.999 × 10 9 /L), moderate in 50.7% (1.000−2.999 × 10 9 /L), and severe in 12% (≥ 3.000 × 10 9 /L). The WBC counts and ANC climaxed after birth, then gradually decreased and became stable after the fifth week of life. The eosinophil count was significantly higher in infants with BPD during their first week of life. Higher eosinophil counts were associated with sepsis.
The results of this study showed an inverse relationship between the incidence of eosinophilia and gestational age, as found in earlier studies.
1,4,5 The incidence of eosinophilia in this study was similar to those in other studies of infants of similar gestational ages. 1 The current study revealed that the elevated eosinophil count was correlated with the eosinophil percentage, and not with an elevation of WBC count, in patients with eosinophilia. This represented a significant difference between the eosinophilia and non-eosinophilia groups. Pre vious reports have suggested that eosinophilia may be associated with numerous conditions such as the establishment of an anabolic state, drug reactions, and response to foreign antigens. 19−22 However, no specific conditions were associated with eosinophilia in this study. This could be because the subjects were VLBW infants, and the incidences of intubation (54.9%) and parenteral nutrition (89%) were therefore high.
Both reports by Mouzinho et al 14 and the current study revealed that initial high WBC counts and neutrophil counts in VLBW infants decreased with increasing time since birth.
14,23,24 Sandra et al 24 found that initial high WBC and neutrophil counts in infants under 27 weeks' gestational age could persist for 3 weeks, and would then decrease at the fourth week after birth. However, this phenomenon was not demonstrated in the present study. In our study, 25.2% of infants and 5.8% of total CBC data revealed neutropenia, and 70.3% of infants and 18.5% of total CBC data revealed neutrophilia. Our patients appeared to have a lower incidence of neutropenia than those in this earlier study. This discrepancy could be due to their higher incidence of NEC (6 infants required surgical treatment, and 8 required medical treatment with an overall mortality of 36%), contributing to the significant relationship with neutropenia in their study. 24 Further investigation is needed to clarify the influence of a lower incidence of NEC (17 infants out of 107, 15.8%; 16 infants had NEC stage I, 3 infants had NEC stage IIa, all infants were treated medically, and mortality was 0%) on the incidence of neutropenia. The definition of neutropenia used in the current study was ANC less than 1.100 × 10 9 /L, which was lower than the commonly used definition of ANC less than 1.500 × 10 9 /L , 24, 25 and may also have contributed to the differences between the studies. It is also possible that the higher incidence of sepsis in our study may have contributed to the higher incidence of neutrophilia, compared with a previous study. 23 Fluconazole is the drug most frequently discussed in association with eosinophilia. 26 Current practice at the National Cheng Kung University Hospital is for preterm infants with birth weights under 1200 g to routinely receive prophylactic fluconazole to prevent fungemia and its associated morbidity and mortality. Therefore, 73.8% of infants received fluconazole. 
Figure 4
Average changes in white blood cell (WBC), neutrophil and eosinophil counts over the observation period. WBC and neutrophil count were significantly correlated throughout the whole observation period (p < 0.01). The pattern of changes in eosinophil counts differed from those in WBC and neutrophil counts. There was no significant difference in the incidences of eosinophilia between those treated with fluconazole and those who were not (74.7% vs. 71.9%, p = 0.764). Previous studies, however, found a significant association between fungemia and eosinophilia. 21, 26 There was one infant in the current study with a body weight of 1250 g who did not receive fluconazole prophylaxis and who developed fungemia. The incidence of eosinophilia in this study was not affected by reduced fungemia with prophylactic use of fluconazole.
In our study, 86 infants (82.7%) received prenatal steroid therapy, while 18 (17.3%) did not. There were no significant differences between these two groups in terms of WBC counts, eosinophil counts, or eosinophil percentages. A similar result was found in a cohort study conducted by Morag et al 27 in 196 VLBW infants. Calhoun et al, 28 in a study of bone marrow samples from VLBW infants born at under 30 weeks' gestational age, revealed an increased production of neutrophils from the bone marrow, suggesting a kinetic mechanism in the bone marrow as the main cause of leukocytosis, rather than a corticosteroidinduced mechanism. Previous studies have shown eosinophilia to be associated with infection. 1, 9, 18, 21, 22 In this study, 50.5% Figure 6 Effect of sepsis on eosinophil counts. Eosinophil counts in very low birth-weight infants with sepsis were higher than those without sepsis at the first, third, fourth, fifth and seventh weeks (p < 0.05). However, the eosinophil counts were similar during the second, sixth and eighth weeks of postnatal age. *p < 0.05. of these VLBW infants had infections during the period of admission, and 78% of these had eosinophilia. The eosinophil count was significantly higher in cases with sepsis, in accordance with results from previous studies. 1, 9, 20, 22, 26 Eosinophil granules contain eosinophil cationic protein, eosinophil peroxidase, and eosinophil-derived neurotoxin, as well as various cytokines and lipid mediators generated after cellular activation. Eosinophils thus produce unique toxic inflammatory mediators and perform a characteristic role in the process of infec tion. 1,29−31 Eosinophilia may be harmful because of the proinflammatory effects of eosinophils and destruction of tissue, 7, 10, 31 which could explain why the eosinophil count was significantly higher in patients with sepsis in our study. The absence of any relationship between sepsis and eosinophilia in the second, sixth and eighth weeks of life could be due to the fact that the majority of the infants received at least 3 days of prophylactic antibiotics in their first week of admission to the NICU, which might have decreased the incidence of sepsis at the second week (only 6 blood culture-positive cases in the second week). The differences during the sixth and eighth weeks of life were not significant, possibly because there were very few culture-proven cases, only four and three cases, respectively. The eosinophil count and WBC count were significantly greater in the sepsis group than those of the non-sepsis group (at 2, 6 and 8 weeks). Meanwhile, the eosinophil percentage was not correlated with eo sinophil count in patients with sepsis, suggesting an overwhelming leukocytosis in sepsis that blurred the correlation between eosinophil count and its percentage. These results suggest that WBC alone is inadequate for diagnosing clinical infection; eosinophil count and percentage are also important measures for the diagnosis of clinical infection in non-septic VLBW infants.
Survival of VLBW infants has improved significantly over recent decades, but the incidence of BPD remains high and BPD is still regarded as a major cause of morbidity. 17, 32 Previous studies have reported controversial results regarding the relationship between BPD and eosinophilia. 3−5 In this study, we found that the eosinophil count was significantly higher in infants with BPD during their first week of life (p < 0.05), after which the eosinophil counts decreased at the third, fourth and fifth weeks of life compared to those of the infants without BPD. Postnatal steroids were used to wean ventilator-dependent infants. However, no significant effect of steroid treatment was observed in these cases (p = 0.075). Twenty infants with BPD were given postnatal steroids between days 14 and 82. Sixty percent of these infants received steroids between the 20 th and 39 th of life. It is possible that the lack of any significant relationship may have been due to the small number of cases (there were only four cases who received postnatal steroids but were without eosinophilia). Previous studies, however, found that the use of steroids was associated with a decreased eosinophil count. 7, 27 Approximately 71% of the infants (71/107) received PRBC transfusions in the current study. There was no relationship between the weekly eosinophil count and PRBC transfusion 1 week before, or between eosinophilia and transfusion of PRBC as a whole. 1, 19, 20 In contrast to earlier studies that revealed an association between eosinophilia and positive weight gain, 33 we found no correlation between recorded body weight gain and eosinophil count in the present study. However, infants in the present study did not vary significantly in terms of their birth weights, in contrast to other study populations which showed diverse birth weights. This could account for the significant differences detected in their studies.
In conclusion, there was a high incidence of eosinophilia in VLBW infants in our investigation. The peak eosinophil count occurred during the third week of life. The WBC counts and ANC climaxed after birth, then gradually decreased and became stable at the fifth week of life. Higher eosinophil counts were significantly associated with sepsis and a family history of atopic eczema. Infants with BPD also had higher eosinophil counts in their first week of life.
